Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection von Kerman, R.H., Susskind, B., Kerman, D.H., Lam, M., Gerolami, K., Williams, J., Kalish, R., Campbell, M., Katz, S.M., Van Buren, C.T., Kahan, B.D.

Volltext

Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection von KERMAN, R. H, SUSSKIND, B, KAHAN, B. D, BUELOW, R, REGAN, J, POULETTY, P, WILLIAMS, J, GEROLAMI, K, KERMAN, D. H, KATZ, S. M, VAN BUREN, C. T

Volltext

Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients von KERMAN, R. H, VAN BUREN, C. T, LEWIS, R. M, DEVERA, V, BAGHDAHSARIAN, V, GEROLAMI, K, KAHAN, B. D

Volltext

PRA-STAT identifies high-risk, alloimune recipients von Kerman, R, Susskind, B, Kerman, D, Lam, M, Kalish, R, Gerolami, K, Katz, S, Frazier, OH, Radovancevic, B, Van Buren, CT, Kahan, BD

Volltext

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma von Finn, Richard S, Qin, Shukui, Ikeda, Masafumi, Galle, Peter R, Ducreux, Michel, Kim, Tae-You, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed O, Li, Daneng, Verret, Wendy, Xu, Derek-Zhen, Hernandez, Sairy, Liu, Juan, Huang, Chen, Mulla, Sohail, Wang, Yulei, Lim, Ho Yeong, Zhu, Andrew X, Cheng, Ann-Lii

Volltext

Letter: nutritional benefits of rifaximin in cirrhotic patients von Borentain, P., Rouabah, K., Allard, G., Ressiot, E., Gerolami, R.

Volltext

1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study von Merle, P., Lim, H.Y., Finn, R.S., Ikeda, M., Kudo, M., Frenette, C., Masi, G., Kim, Y.J., Gerolami, R., Kurosaki, M., Numata, K., Klümpen, H-J., Zebger-Gong, H., Fiala-Buskies, S., Ozgurdal, K., Qin, S.

Volltext

Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international retrospective comparative cohort study von Jones, K.J.E, Van Eijk, J.J.J, Ripellino, P, Madden, R.G, Herrod, J, Lissmann, R, Webb, G, Abdelrahim, M, Ashraf, H.H, Almasri, O, Mclean, B.N.P, Gobbi, C, Moradpour, D, Kuntzer, T, Benninger, D, Fraga, M, Sahli, R, Peron, J.M, Blasco-Perrin, H, Izopet, J, Colson, P, Attarian, S, Gerolami, R, Hartl, J, Pischke, S, Giordani, M.T, Fritz, M, Panning, M, Bendall, R.P, Lin, N, Van Alfen, N, Van Engelen, B, Jacobs, B.C, Dalton, H.R

Volltext

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study von Payan, C., Roudot-Thoraval, F., Marcellin, P., Bled, N., Duverlie, G., Fouchard-Hubert, I., Trimoulet, P., Couzigou, P., Cointe, D., Chaput, C., Henquell, C., Abergel, A., Pawlotsky, J. M., Hezode, C., Coudé, M., Blanchi, A., Alain, S., Loustaud-Ratti, V., Chevallier, P., Trepo, C., Gerolami, V., Portal, I., Halfon, P., Bourlière, M., Bogard, M., Plouvier, E., Laffont, C., Agius, G., Silvain, C., Brodard, V., Thiefin, G., Buffet-Janvresse, C., Riachi, G., Grattard, F., Bourlet, T., Stoll-Keller, F., Doffoel, M., Izopet, J., Barange, K., Martinot-Peignoux, M., Branger, M., Rosenberg, A., Sogni, P., Chaix, M. L., Pol, S., Thibault, V., Opolon, P., Charrois, A., Serfaty, L., Fouqueray, B., Grange, J. D., Lefrère, J. J., Lunel-Fabiani, F.

Volltext

Characterization of GaN Switches for Solar Invertors von Gachovska, Tanya, Radimov, Nikolay, Gerolami, Chris, Orr, Ray, Hudgins, Jerry L, Shenai, Krishna

Volltext

Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy von Martinot-Peignoux, M., Roudot-Thoraval, F., Mendel, I., Coste, J., Izopet, J., Duverlie, G., Payan, C., Pawlotsky, J. M., Defer, C., Bogard, M., Gerolami, V., Halfon, P., Buisson, Y., Fouqueray, B., Loiseau, P., Lamoril, J., Lefrere, J. J., Marcellin, P.

Volltext